AIF1 and obesity disorder: Collectively, AIF1 secreted by adipose-tissue macrophages is an important crosstalk mediator in the physiology of adipocytes, and AIF1 deregulation is involved in obesity, so it may be a potential therapeutic target for anti-obesity treatments.